ABIOMED's net profit under GAAP for the 3 months of fiscal 2021 was $44,588 million, down 2-fold from $88,923 million the previous year. Revenue decreased by 20.6% to $164.85 million compared to $207.666 million a year earlier.
ABIOMED's net profit under GAAP for the 3 months of fiscal 2021 was $44,588 million, down 2-fold from $88,923 million the previous year. Revenue decreased by 20.6% to $164.85 million compared to $207.666 million a year earlier. 
investors.abiomed.com
English (US) 